MAYZENT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 28 Apr 2025)
What this means for you
Registered since 27 Aug 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87816240
- Registration number
- 5846370
- Mark type
- Stylized text
- Filed
- 01 Mar 2018
- Published for opposition
- 07 Aug 2018
- Registered
- 27 Aug 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the central nervous system, the immune system, the metabolic system and the musculo-skeletal system; pharmaceutical preparations for the treatment of inflammatory disorders and pain; pharmaceutical preparations for the prevention and treatment of hormonal deficiency and metabolic disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 28 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 28 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 28 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Jan 2025 — TEAS SECTION 8 & 15 RECEIVED
- 27 Aug 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Aug 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Jul 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Jul 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Jun 2019 — USE AMENDMENT FILED
- 16 Jul 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jun 2019 — TEAS STATEMENT OF USE RECEIVED
- 03 Apr 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2019 — SOU EXTENSION 1 GRANTED
- 01 Apr 2019 — SOU EXTENSION 1 FILED